News / Taiwan / economic_daily
PharmaEssentia October Revenue Doubles on Strong Ropeg Sales
Health Technology · Biotechnology · economic_daily · 2026-11-05
6446
PharmaEssentia reported record-high October revenue of 2.84 billion TWD, driven by robust U.S. sales of its Ropeg injection pen and expansion into the ET market.
What Happened
Record Revenue: PharmaEssentia achieved a record-high monthly revenue of 2.84 billion TWD in October, marking a 102% year-over-year increase. Strong demand for its core product, Ropeg, in the Polycythemia Vera (PV) market served as the primary growth driver.
Market Expansion: The launch of the Ropeg injection pen in the U.S. and the commercialization of the Essential Thrombocythemia (ET) indication in major markets like Japan are accelerating growth. The company is also actively expanding into the Asia-Pacific region, with regulatory filings underway in Australia.
Clinical Validation: Recent studies highlight Ropeg's potential as a disease-modifying therapy, showing consistent efficacy across diverse patient populations. This clinical evidence is strengthening the drug's position in the global medical community for long-term treatment.
Investor Engagement: PharmaEssentia is actively participating in major international healthcare conferences, including events hosted by Jefferies and Citi. These engagements allow the company to update global institutional investors on its operational progress and strategic expansion in the MPN field.
Read original
More in Health Technology
Health Technology · economic_daily · 2026-11-05
US healthcare stocks surged on expectations of favorable policy continuity following Democratic election gains, fueling a rally in Taiwan's biotech sector, led by strong earnings and new product approvals from companies like Bora Pharmaceuticals.
1786, 1795, 6446, 6472, 6782, 6919, 6949
Health Technology · economic_daily · 2026-11-04
Kao Hsing Chang has sold 353,000 shares of PharmaEssentia, generating a profit of NT$61.39 million to bolster its non-operating income.
2008
Health Technology · economic_daily · 2026-11-04
St. Shine Optical reported record-breaking Q3 earnings as increased production capacity at its Malaysian facility boosted shipments to European and American markets.
6782
Latest in Taiwan
Finance · economic_daily · 2026-11-05
Taiwan's stock market faced a historic downturn with foreign investors offloading a record 942.18 billion TWD in October, marking the largest monthly sell-off since 2022.
Finance · economic_daily · 2026-11-05
Fubon Investment warns of potential margin calls as the Taiwan stock market faces volatility, projecting a Q4 range between 40,000 and 50,000 points.
Consumer Non-Durables · economic_daily · 2026-11-05
Uni-President Enterprises achieved record-breaking results in the first nine months, with net profit rising 26% to 21 billion TWD and EPS reaching 3.7 TWD.
1216
Consumer Services · economic_daily · 2026-11-05
Wowprime Corporation achieved a record-breaking performance in the first three quarters, with EPS reaching 14.32 yuan, as the company prepares for a strong Q4.
2727